Atlas Trials

Sandoz

139 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Sandoz

RecordFirmDate
Study to Evaluate the Therapeutic Equivalence and Safety of Fluticasone Furoate and Vilanterol Inhalation Powder 100 mcg/25 mcg and BREO ELLIPTA 100 mcg/25 mcg in Participants With Asthma (NCT07223294)Sandoz2026-04-21
Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis (NCT06847724)Sandoz2025-06-10
Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy® (NCT06587451)Sandoz2024-12-19
Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold (NCT05070650)Sandoz2024-09-20
A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma (NCT06153238)Sandoz2024-05-15
A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (NCT06159790)Sandoz2024-04-29
Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis (NCT05887843)Sandoz2023-06-08
Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting (NCT05633771)Sandoz2023-02-16
Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis. (NCT05590598)Sandoz2023-02-13
Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Vial Kit (NCT05282004)Sandoz2022-05-16
A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer (NCT05258747)Sandoz2022-04-07
Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis (NCT05311475)Sandoz2022-04-04
Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled Syringe (NCT05161806)Sandoz2022-03-11
Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With Neovascular Age-related Macular Degeneration (NCT04864834)Sandoz2021-05-12
Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis (NCT04123405)Sandoz2020-10-22
Study of LRG-002 Hard Capsules (Lek d.d., Slovenia) Used in the Prophylaxis of Antibiotic-associated Diarrhea in Adults. (NCT04321460)Sandoz2020-10-01
An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Transdermal Patches Containing Rotigotine. (NCT04183634)Sandoz2019-12-03
Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients. (NCT03978494)Sandoz2019-09-02
Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients With Postmenopausal Osteoporosis (NCT03974100)Sandoz2019-07-02
Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia. (NCT03993288)Sandoz2019-06-27
Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease (NCT03890445)Sandoz2019-06-24
This Was a Clinical Study Investigating the Moisturization and Desquamation Effect of AmLactin® Rapid Relief Restoring Lotion + Ceramides on Dry Skin in Healthy Female Volunteers. AmLactin® Rapid Relief is an Over-the-counter Cosmetic (NCT04085809)Sandoz2019-03-26
In Vivo Performance of Oral Liquid Formulations of Budesonide in the Fasted State in Healthy Subjects (NCT05429775)Sandoz2018-12-26
Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery (NCT03531697)Sandoz2018-04-26
A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia (NCT03399084)Sandoz2017-11-29
Next →

Track Sandoz automatically

Every clearance here is in the API, with alerts when new ones post.